1. Skin manifestations of a case of phenylbutazone-induced serum sickness-like reactions.
- Author
-
Sánchez G, Vila L, Pajarón M, and Diéguez I
- Subjects
- Adult, Anti-Inflammatory Agents, Non-Steroidal therapeutic use, Anxiety complications, Anxiety drug therapy, Depression complications, Depression drug therapy, Drug Hypersensitivity etiology, Exanthema diagnosis, Exanthema pathology, Exanthema therapy, Female, Humans, Lymphatic Diseases diagnosis, Lymphatic Diseases pathology, Lymphatic Diseases therapy, Phenylbutazone therapeutic use, Anti-Inflammatory Agents, Non-Steroidal adverse effects, Exanthema chemically induced, Lymphatic Diseases chemically induced, Phenylbutazone adverse effects
- Abstract
Serum sickness consists of a systemic reaction resulting from the formation of soluble circulating immunocomplexes after the introduction of a foreign substance into the body We studied a 38-year-old woman diagnosed with anxiety, depression and right sacroileitis who was treated with phenylbutazone, ranitidine, clomipramine and levomepromazine. After taking this treatment for 1 month, she presented with fever, diarrhea, localized edemas, generalized pruritic papular and erythematous rash and lymphadenopathies. She presented the same symptoms after oral intake of metamizole. The diagnosis was confirmed following a single-blind, placebo-controlled provocation test with phenylbutazone and a biopsy of the affected skin.
- Published
- 2000